Category: Research and Development

November 17, 2020

Parkinson’s disease (PD) is a progressive disorder that affects nerve cells in the brain responsible for body movement. When dopamine-producing neurons die, symptoms such as tremor, slowness, stiffness, and balance problems occur. Researchers at Carnegie Mellon University (CMU) have developed […]

November 12, 2020

Scientists have developed a new method that allows them to select individual cells from a population that is growing on the surface of a laboratory dish, and then study their contents using DNA and protein sequencing technologies to analyze the […]

November 11, 2020

Nerve tissue engineering is an application of tissue engineering in peripheral nerve regeneration, and tissue-engineered nerve grafts, like other tissue-engineered constructs, are typically composed of a nerve scaffold combined with cellular and/or molecular components. A team of researchers from RMIT […]

November 9, 2020

According to the National Cancer Institute, about 10% of patients with pancreatic cancer (PC) remain alive five years after diagnosis. Tumor size has a strong impact on survival rates. The larger the tumor, the less likely it is to be […]

November 6, 2020

The Food and Drug Administration announced on Friday that it has authorized the first serology test that screens for neutralizing antibodies caused by a previous coronavirus infection. Neutralizing antibodies prevent viruses from infecting cells, though questions remain about how long […]

November 2, 2020

Scientists at the University of Massachusetts, Amherst, have used what they claim is an unprecedented objective approach to identify which genes and molecular pathways— including mechanisms involving aging, lipid metabolism, and autoimmune disease—are most sensitive to chemical exposure. Headed by […]

October 30, 2020

AB2 Bio, a Swiss clinical-stage biotech company developing therapies for the treatment of severe systemic autoinflammatory diseases, and WuXi Biologics agreed to collaborate to set up and accelerate commercial-scale manufacturing of Tadekinig alfa, AB2 Bio’s recombinant IL-18 binding protein. AB2 […]

October 28, 2020

Today, 54gene announced the launch of its Clinical Program Services (CPS) division. The CPS division is focused on partnering with global pharmaceutical and biotechnology companies, and multilateral health organizations to discover, develop, and commercialize new therapeutic and diagnostic products. 54gene, […]

October 27, 2020

Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced updates on its Phase 3 clinical development program of NVX-CoV2373, its COVID-19 vaccine candidate. NVX‑CoV2373 is a stable, prefusion protein made using Novavax’ nanoparticle […]

October 27, 2020

Medigene, clinical stage immuno-oncology company focusing on the development of T cell immunotherapies for cancer, entered into a service agreement with Cytovant Sciences to support process development activities for the manufacturing of dendritic cell (DC) vaccines. The deal builds on […]

October 23, 2020

Alnylam has shared data from a phase 3 trial of its near-approval kidney disease drug lumasiran in children as young as three months. The RNAi therapy drove a 72% reduction in urinary oxalate from baseline, boosting Alnylam’s hopes of using […]

October 23, 2020

Understanding how SARS-CoV-2 infection damages the lungs is paramount to developing better treatments. Now, “mini-lungs” grown from tissue donated to Cambridge hospitals has provided a team of scientists with important insights into how COVID-19 damages the lungs. In new work, […]